ActoBio Therapeutics, Inc.

9:15 AM - 9:30 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
ActoBio Therapeutics is an innovative, clinical stage biotechnology company pioneering a new class of microbe-based biopharmaceuticals, ActoBiotics®, that enable expression and local delivery of disease-modifying therapeutics.
The ActoBiotics platform produces biologics through oral or local administration with treatment applications across many diseases. This approach is being developed to provide safer and more efficacious treatments than injectable biologicals. ActoBio Therapeutics has a strong R&D pipeline and several therapeutic programs in advanced developmental stages, including Phase 1b/2a and Phase 2b clinical trials. For further information and updates please visit us at www.actobio.com.
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Belgium
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
AG013 and AG019
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided